Evidence map›Paper›PMID 37235022›Full record

ArticleFrontiers in plant science2023

Performance of testers with contrasting provitamin A content to evaluate provitamin A maize for resistance to

M Mboup, A O Aduramigba-Modupe, A-R S Maazou, B Olasanmi, W Mengesha, S Meseka, I Dieng, R Bandyopadhyay, A Menkir, A Ortega-Beltran

Abstract read
In one paragraph

Article in Frontiers in plant science, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

M MboupPan African University Life and Earth Sciences Institute (including Health and Agriculture), University of Ibadan, Ibadan, Nigeria.
A O Aduramigba-ModupeDepartment of Crop Protection and Environmental Biology, Faculty of Agriculture, University of Ibadan, Ibadan, Nigeria.
A-R S MaazouInternational Institute of Tropical Agriculture (IITA), Ibadan, Nigeria.
B OlasanmiDepartment of Crop and Horticultural Sciences, Faculty of Agriculture, University of Ibadan, Ibadan, Nigeria.
W MengeshaInternational Institute of Tropical Agriculture (IITA), Ibadan, Nigeria.
S MesekaInternational Institute of Tropical Agriculture (IITA), Ibadan, Nigeria.
I DiengInternational Institute of Tropical Agriculture (IITA), Ibadan, Nigeria.
R BandyopadhyayInternational Institute of Tropical Agriculture (IITA), Ibadan, Nigeria.
A MenkirInternational Institute of Tropical Agriculture (IITA), Ibadan, Nigeria.
A Ortega-BeltranInternational Institute of Tropical Agriculture (IITA), Ibadan, Nigeria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In sub-Saharan Africa (SSA), millions of people depend on maize as a primary staple. However, maize consumers in SSA may be exposed to malnutrition due to vitamin A deficiency (VAD) and unsafe aflatoxin levels, which can lead to serious economic and public health problems. Provitamin A (PVA) biofortified maize has been developed to alleviate VAD and may have additional benefits such as reduced aflatoxin contamination. In this study, maize inbred testers with contrasting PVA content in grain were used to identify inbred lines with desirable combining ability for breeding to enhance their level of resistance to aflatoxin. Kernels of 120 PVA hybrids generated by crossing 60 PVA inbreds with varying levels of PVA (5.4 to 51.7 µg/g) and two testers (low and high PVA, 14.4 and 25.0 µg/g, respectively) were inoculated with a highly toxigenic strain of

Indexed as

aflatoxincarotenoidsprovitamin Atesterstropical maize

Identifiers

PMID37235022
PMCPMC10206313

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.